Metabolic activation and detoxification of polycyclic aromatic hydrocarbons

The Carcinogenic Effects of Polycyclic Aromatic Hydrocarbons

Volumn , Issue , 2005, Pages 19-96

  Luch, Andreas ^a   Baird, William M ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84967546681     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9781860949333_0002     Document Type: Chapter

References (405)

1. Miller EC (1978) Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidental address. Cancer Res. 38: 1479-1496.
2. Pelkonen O and Nebert DW (1982) Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol. Rev. 34: 189-222.
3. Thakker DR, Yagi H, Levin W, Wood AW, Conney AH and Jerina DM (1985) Polycyclic aromatic hydrocarbons: metabolic activation to ultimate carcinogens. In: Bioactivation of Foreign Compounds [Anders MW (ed.)] pp 177-242, Academic Press, London.
4. Guengerich FP (1988) Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res. 48: 2946-2954.
5. Harvey RG (1991) Metabolic activation, DNA binding, and mechanisms of carcinogenesis. In: Polycyclic Aromatic Hydrocarbons: Chemistry and Carcinogenicity [Harvey RG (ed.)] pp 50-95, Cambridge University Press, Cambridge, UK.
6. Harvey RG and Geacintov NE (1988) Intercalation and binding of carcinogenic hydrocarbon metabolites to nucleic acids. Acc. Chem. Res. 21: 66-73.
7. Skipper PL, Peng X, Soohoo CK and Tannenbaum SR (1994) Protein adducts as biomarkers of human carcinogen exposure. Drug Metab. Rev. 26:111-124.
8. Gamer CR (1998) The role of DNA adducts in chemical carcinogenesis. Mutat. Res. 402: 67-75.
9. Dipple A (1994) Reactions of polycyclic aromatic hydrocarbons with DNA. In: DNA Adducts: Identification and Biological Significance [Hemminki K, Dipple A, Shuker DEG, Kadlubar FF, Segerbäck D and Bartsch H (eds.)] IARC Scientific Publication No. 125, pp 107-129, International Agency for Research on Cancer, Lyon, France.
10. Dipple A, Moschel RC and Bigger CAH (1984) Polynuclear aromatic carcinogens. In: Chemical Carcinogens [Searle CE (ed.)] ACS Monograph 182, pp 41-163, American Chemical Society, Washington, D.C.
11. Dipple A (1985) Polycyclic aromatic hydrocarbon carcinogenesis. In: Polycyclic Hydrocarbons and Carcinogenesis [Harvey RG (ed.)] ACS Symposium Series 283, pp 1-17, American Chemical Society, Washington, D.C.
12. Chang RL, Levin W, Wood AW, Lehr RE, Kumar S, Yagi H, Jerina DM and Conney AH (1981) Tumorigenicity of the diastereomeric bay-region benzo[e]pyrene 9,10-diol-l 1,12-epoxides in newborn mice. Cancer Res. 41: 915-918.
13. Deutsch-Wenzel RP, Brune H, Grimmer G, Dettbam G and Misfeld J (1983) Experimental studies in rat lungs of the carcinogenicity and dose-response relationship of eight frequently occurring PAHs. J. Natl. Cancer Inst. 71: 539-544.
14. Osborne MR and Crosby NT (1987) Benzo[e]pyrene. In: Benzopyrenes [Osborne MR and Crosby NT (eds.)] Cambridge Monographs on Cancer Research, pp 229-250, Cambridge University Press, Cambridge, UK.
15. Cavalieri E, Mailander P and Pelfrene A (1977) Carcinogenic activity of anthanthrene on mouse skin. Z. Krebsforsch. 89: 113-118.
16. Scribner JD (1973) Tumor initiation by apparently noncarcinogenic polycyclic aromatic hydrocarbons. J. Natl. Cancer Inst. 50: 1717-1719.
17. Badger GM (1948) The carcinogenic hydrocarbons: chemical constitution and carcinogenic activity. Br. J. Cancer 2: 309-350.
18. Boyland E and Sims P (1967) The carcinogenic activity in mice of compounds related to benz[a]anthracene. Int. J. Cancer 2: 500-504.
19. Dipple A, Lawley PD and Brookes P (1968) Theory of tumour initiation by chemical carcinogens: dependence of activity on structure of ultimate carcinogen. Eur. J. Cancer 4: 493-506.
20. Hoffmann D, Bondinell WE and Wynder EL (1974) Carcinogenicity of methylchrysenes. Science 183: 215-217.
21. Hecht SS, Loy M, Mazzarese R and Hoffmann D (1978) On the carcinogenicity of 5-methylchrysene: stracture-activity studies and metabolism. In: Polycyclic Hydrocarbons and Cancer [Gelboin HV and Ts’o POP (eds.)] Volume I: Environment, Chemistry, and Metabolism, pp 119-130, Academic Press, New York.
22. Levin W, Wood AW, Chang RL, Newman MS, Thakker DR, Conney AH and Jerina DM (1983) The effect of steric strain in the bay-region of polycyclic aromatic hydrocarbons: tumorigenicity of alkyl-substituted benz[a]anthracenes. Cancer Lett. 20: 139-146.
23. Hecht SS, Amin S, Melikian AA, LaVoie EJ and Hoffmann D (1985) Effects of methyl and fluorine substitution on the metabolic activation and tumorigenicity of polycyclic aromatic hydrocarbons. In: Polycyclic Hydrocarbons and Carcinogenesis [Harvey RG (ed.)] ACS Symposium Series 283, pp 85-105, American Chemical Society, Washington, D.C.
24. Harvey RG (1991) Structure-activity relationships. In: Polycyclic Aromatic Hydrocarbons: Chemistry and Carcinogenicity [Harvey RG (ed.)] pp 26-49, Cambridge University Press, Cambridge, UK.
25. Wislocki PG, Juliana MM, MacDonald JS, Chou MW, Yang SK and Lu AY (1981) Tumorigenicity of 7,12-dimethylbenz[a]anthrancene, its hydroxymethylated derivatives and selected dihydrodiols in the newborn mouse. Carcinogenesis 2: 511-514.
26. Harvey RG, Cortez T, Sugiyama T, Ito Y, Sawyer TW and DiGiovanni J (1988) Biologically active dihydrodiol metabolites of polycyclic aromatic hydrocarbons structurally related to the potent carcinogenic hydrocarbon 7,12- dimethylbenz[a]anthracene. J. Med. Chem. 31: 154-159.
27. Cavalieri EL, Higginbotham S, Rama Krishna NVS, Devanesan PD, Todorovic R, Rogan EG and Salmasi S (1991) Comparative dose-response tumorigenicity studies of dibenzo[a, l]pyrene versus 7,12-dimethylbenz[a]- anthracene, benzo[a]pyrene and two dibenzo[a,l]pyrene dihydrodiols in mouse skin and rat mammary gland. Carcinogenesis 12: 1939-1944.
28. Higginbotham S, Rama Krishna NVS, Johansson SL, Rogan EG and Cavalieri EL (1993) Tumor-initiating activity and carcinogenicity of dibenzo- [a, l]pyrene versus 7,12-dimethylbenz[a]anthrancene andbenzo[a]pyrene at low doses in mouse skin. Carcinogenesis 14: 875-878.
29. Boyland E and Weigert F (1947) Metabolism of carcinogenic compounds. Br. Med. Bull. 4: 354-359.
30. Boyland E (1950) The biological significance of metabolism of polycyclic compounds. Biochem. Soc. Symp. 5: 40-54.
31. Coulson CA (1953) Electronic configuration and carcinogenesis. Adv. Cancer Res. 1: 1-56.
32. Pullman A and Pullman B (1955) Electronic structure and carcinogenic activity of aromatic molecules. New developments. Adv. Cancer Res. 3: 117-169.
33. Newman MS and Blum S (1964) A new cyclization reaction leading to epoxides of aromatic hydrocarbons. J. Am. Chem. Soc. 86: 5598-5600.
34. Miller EC and Miller JA (1967) Low carcinogenicity of the K-region epoxides of 7-methylbenz[a]anthracene and benz[a]anthracene in the mouse and rat. Proc. Soc. Exp. Biol. Med. 124: 915-919.
35. Sims P (1967) The carcinogenic activities in mice of compounds related to 3-methylcholanthrene. Int. J. Cancer 2: 505-508.
36. Van Duuren BL, Langseth L, Goldschmidt BM and Orris L (1967) Carcinogenicity of epoxides, lactones, and peroxy compounds. VI. Structure and carcinogenic activity. J. Natl. Cancer Inst. 39: 1217-1228.
37. Sims P and Grover PL (1974) Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis. Adv. Cancer Res. 20:165-174.
38. Baird WM, Harvey RG and Brookes P (1975) Comparison of the cellular DNA-bound products of benzo[a]pyrene with the products formed by reaction of benzo[a]pyrene-4,5-oxide with DNA. Cancer Res. 35: 54-57.
39. Conney AH, Miller EC and Miller JA (1956) The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. Cancer Res. 16: 450-459.
40. Conney AH, Miller EC and Miller JA (1957) Substrate-induced synthesis and other properties of benzpyrene hydroxylase in rat liver. J. Biol. Chem. 228: 753-766.
41. Sladek NE and Mannering GJ (1966) Evidence for a new P-450 hemoprotein in hepatic microsomes from methylcholanthrene treated rats. Biochem. Biophys. Res. Commun. 24: 668-674.
42. Gelboin HV (1967) Carcinogens, enzyme induction, and gene action. Adv. Cancer Res. 10: 1-81.
43. Nebert DW and Gelboin HV (1968) Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme. J. Biol. Chem. 243: 6242-6249.
44. Conney AH (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes Memorial Lecture. Cancer Res. 42: 4875-4917.
45. Grover PL and Sims P (1968) Enzyme-catalyzed reactions of polycyclic hydrocarbons with deoxyribonucleic acid and protein in vitro. Biochem. J. 110: 159-160.
46. Gelboin HV (1969) A microsome-dependent binding of benzo[a]pyrene to DNA. Cancer Res. 29: 1272-1276.
47. Borgen A, Darvey H, Castagnoli N, Crocker TT, Rasmussen RE and Wang IY (1973) Metabolic conversion of benzo[a]pyrene by Syrian hamster liver microsomes and binding of metabolites to deoxyribonucleic acid. J. Med. Chem. 16: 502-506.
48. Sims P, Grover PL, Swaisland A, Pal K and Hewer A (1974) Metabolic activation of benzo[a]pyrene proceeds by a diol-epoxide. Nature 252: 326-328.
49. Jerina DM and Daly JW (1974) Arene oxides: a new aspect of drug metabolism. Metabolic formation of arene oxides explains many toxic and carcinogenic properties of aromatic hydrocarbons. Science 185: 573-582.
50. Daudel P, Duquesne M, Vigny P, Grover PL and Sims P (1975) Fluorescence spectral evidence that benzo[a]pyrene-DNA products in mouse skin arise from diol-epoxides. FEBS Lett. 57: 250-253.
51. Marquardt H, Grover PL and Sims P (1976) In vitro malignant transformation of mouse fibroblasts by non-K-region dihydrodiols derived from 7-methylbenz[a]anthracene, 7,12-dimethylbenz[a]anthracene, and benzo[a]pyrene. Cancer Res. 36: 2059-2064.
52. Wood AW, Levin W, Lu AY, Ryan D, West SB, Lehr RE, Schaefer-Ridder M, Jerina DM and Conney AH (1976) Mutagenicity of metabolically activated benz[a]anthracene 3,4-dihydrodiol: evidence for bay region activation of carcinogenic polycyclic aromatic hydrocarbons. Biochem. Biophys. Res. Commun. 72: 680-686.
53. King HWS, Osborne MR, Beland FA, Harvey RG and Brookes P (1976) (±)-7α,8β-dihydroxy-9β,10β-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene is an intermediate in the metabolism and binding to DNA of benzo[a]pyrene. Proc. Natl. Acad. Sci. USA 73: 2679-2681.
54. Osborne MR, Beland FA, Harvey RG and Brookes P (1976) The reaction of(±)-7α,8β-dihydroxy-9β,10β-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene with DNA. Int. J. Cancer 18: 362-368.
55. Weinstein I, Jeffrey AM, Jennette KW, Blobstein SH, Harvey RG, Harris C, Autrup H, Kasai H and Nakanishi K (1976) Benzo[a]pyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo. Science 193: 592-595.
56. Newbold RF and Brookes P (1976) Exceptional mutagenicity of benzo- [a]pyrene diol epoxide in cultured mammalian cells. Nature 261: 52-54.
57. Huberman E, Sachs L, Yang SK and Gelboin HV (1976) Identification of mutagenic metabolites of benzo[a]pyrene in mammalian cells. Proc. Natl. Acad. Sci. USA 73: 607-611.
58. Jeffrey AM, Weinstein IB, Jennette KW, Grzeskowiak K, Nakanishi K, Harvey RG, Autrup H and Harris C (1977) Structures of benzo[a]pyrenenucleic acid adducts formed in human and bovine bronchial explants. Nature 269: 348-350.
59. Levin W, Wood AW, Wislocki PG, Chang RL, Kapitulnik J, Mah HD, Yagi H, Jerina DM and Conney AH (1978) Mutagenicity and carcinogenicity of benzo[a]pyrene and benzo[a]pyrene derivatives. In: Polycyclic Hydrocarbons and Cancer [Gelboin HV and Ts’o POP (eds.)] Volume I: Environment, Chemistry, and Metabolism, pp 189-202, Academic Press, New York.
60. Chouroulinkov I, Gentil A, Grover PL and Sims P (1976) Tumour initiating activities on mouse skin of dihydrodiols derived from benzo[a]pyrene. Br. J. Cancer 34: 523-532.
61. Levin W, Wood AW, Yagi H, Jerina DM and Conney AH (1976) (±.)-Trans- 7,8- dihydroxy-7,8-dihydrobenzo[a]pyrene: a potent skin carcinogen when applied topically to mice. Proc. Natl. Acad. Sci. USA 73: 3867-3871.
62. Kapitulnik J, Levin W, Conney AH, Yagi H and Jerina DM (1977) Benzo[a]pyrene 7,8-dihydrodiol is more carcinogenic than benzo[a]pyrene in newborn mice. Nature 266: 378-380.
63. Slaga TJ, Gleason GL, Mills G, Ewald L, Fu PP, Lee HM and Harvey RG (1980) Comparison of the skin tumor-initiating activities of dihydrodiols and diol-epoxides of various polycyclic aromatic hydrocarbons. Cancer Res. 40: 1981-1984.
64. Yagi H, Hernandez O and Jerina DM (1975) Synthesis of (±)-7α,8β- dihydroxy-9β,10β-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene, a potential metabolite of the carcinogen benzo[a]pyrene with stereochemistry related to the antileukemic tripolides. J. Am. Chem. Soc. 97: 6881-6883.
65. Yagi H, Thakker DR, Hernandez O, Koreeda M and Jerina DM (1977) Synthesis and reactions of the highly mutagenic 7,8-diol 9,10-epoxides of the carcinogen benzo[a]pyrene. J. Am. Chem. Soc. 99: 1604-1611.
66. Harvey RG and Fu PP (1978) Synthesis and reactions of diol epoxides and related metabolites of carcinogenic hydrocarbons. In: Polycyclic Hydrocarbons and Cancer [Gelboin HV and Ts’o POP (eds.)] Volume I: Environment, Chemistry, and Metabolism, pp 133-165, Academic Press, New York.
67. Jerina DM and Lehr RE (1977) The bay-region theory: a quantum mechanical approach to aromatic hydrocarbon-induced carcinogenicity. In: Microsomes and Drug Oxidations [Ullrich V, Roots I, Hildebrandt A, Estabrook RW and Conney AH (eds.)] pp 709-720, Pergamon Press, Oxford, UK.
68. Jerina DM, Lehr R, Schaefer-Ridder M, Yagi H, Karle JM, Thakker DR, Wood AW, Lu AYH, Ryan D, West S, Levin W and Conney AH (1977) Bayregion epoxides of dihydrodiols: a concept explaining the mutagenic and carcinogenic activity of benzo[a]pyrene and benz[a]anthracene. In: Origins of Human Cancer [Hiatt HH, Watson JD and Winstein JA (eds.)] Book B, pp 639-658, Cold Spring Habour, New York.
69. Jerina DM, Yagi H, Lehr RE, Thakker DR, Schaefer-Ridder M, Karle JM, Levin W, Wood AW, Chang RL and Conney AH (1978) The bay-region theory of carcinogenesis by polycyclic aromatic hydrocarbons. In: Polycyclic Hydrocarbons and Cancer [Gelboin HV and Ts’o POP (eds.)] Volume I: Environment, Chemistry, and Metabolism, pp 173-188, Academic Press, New York.
70. Lehr RE, Kumar S, Levin W, Wood AW, Chang RL, Conney AH, Yagi H, Sayer JM and Jerina DM (1985) The bay region theory of polycyclic aromatic hydrocarbon carcinogenesis. In: Polycyclic Hydrocarbons and Carcinogenesis [Harvey RG (ed.)] ACS Symposium Series 283, pp 63-84, American Chemical Society, Washington, D.C.
71. Hall M and Grover PL (1990) Polycyclic aromatic hydrocarbons: metabolism, activation and tumour initiation. In: Chemical Carcinogenesis and Mutagenesis [Cooper CS and Grover PL (eds.)] Volume I, pp 327-372, Springer-Verlag, Berlin.
72. Ioannides C and Parke DV (1990) The cytochrome P450 I gene family of microsomal hemoproteins and their role in the metabolic activation of chemicals. Drug Metab. Rev. 22: 1-85.
73. Guengerich FP (1991) Reactions and significance of cytochrome P-450 enzymes. J. Biol. Chem. 266: 10019-10022.
74. Guengerich IT and Shimada T (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 4: 391-407.
75. Gonzalez FJ (1993) Cytochromes P450 enzymes. In: Handbook of Experimental Pharmacology [Schenkman JB and Greim H (eds.)] Volume 105: Cytochrome P450, pp 239-257, Springer-Verlag, Berlin.
76. Gonzalez FJ and Gelboin HV (1994) Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab. Rev. 26: 165-183.
77. Guengerich FJ (1995) Human cytochrome P450 enzymes. In: Cytochrome P450 - Structure, Mechanism, and Biochemistry [Ortiz de Montellano PR (ed.)] pp 473-535, Plenum Press, New York.
78. Nebert DW and Gonzalez FJ (1987) P450 enzymes: structure, evolution, and regulation. Annu. Rev. Biochem. 56: 945-993.
79. Gonzalez FJ and Nebert DW (1990) Evolution of the P-450 gene superfamily. Pharmacol. Ther. 45: 1-38.
80. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC and Nebert DW (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers, and nomenclature. Pharmacogenetics 6:1-42.
81. Nelson DR (2003) Cytochrome P450 gene superfamily, http://dmelson. utmem.edu/cytochromeP450.html.
82. Shou M, Korzekwa KR, Crespi CL, Gonzalez FJ and Gelboin HV (1994) The role of 12 cDNA-expressed human, rodent, rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol. Mol. Carcinog. 10: 159-168.
83. Kawajiri K and Hayashi SI (1996) The CYP1 family. In: Cytochromes P450 - Metabolic and Toxicological Aspects [Ioannides C (ed.)] pp 77-97, CRC Press, Boca Raton, FL.
84. Shou M, Krausz KW, Gonzalez FJ and Gelboin HV (1996) Metabolic activation of the potent carcinogen dibenzo[a,h]anthracene by cDNA-expressed human cytochromes P450. Arch. Biochem. Biophys. 328: 201-207.
85. Maurel P (1996) The CYP3 family. In: Cytochromes P450 - Metabolic and Toxicological Aspects [Ioannides C (ed.)] pp 241-270, CRC Press, Boca Raton, FL.
86. Baird WM and Ralston SL (1997) Carcinogenic polycyclic aromatic hydrocarbons. In: Comprehensive Toxicology [Sipes IG, McQueen CA and Gandolfi AJ (eds.)] Volume 12: Chemical Carcinogens and Anticarcinogens, pp 171-200, Pergamon Press, Oxford, UK.
87. Shimada T (2000) Human cytochrome P450 IB 1 and chemical carcinogenesis. Rev. Toxicol. 3: 139-166.
88. Williams JA and Phillips DH (2000) Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer. Cancer Res. 60: 4667-4677.
89. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS and Guengerich FP (1996) Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 56: 2979-2984.
90. Larsen MC, Angus WGR, Brake PB, Eltom SE, Sukow KA and Jefcoate CR (1998) Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism. Cancer Res. 58: 2366-2374.
91. Walker NJ, Portier CJ, Lax SF, Crofts FG, Li Y, Lucier GW and Sutter TR (1999) Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 154: 279-286.
92. Shimada T, Sugie A, Shindo M, Nakajima T, Azuma E, Hashimoto M and Inoue K (2003) Tissue-specific induction of cytochromes P450 1A1 and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in engineered C57BL/6J mice of arylhydrocarbon receptor gene. Toxicol. Appl. Pharmacol. 187: 1-10.
93. Ionannides C and Parke DV (1993) Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis. Drug Metab. Rev. 25: 485-501.
94. Shimada T, Inoue K, Suzuki Y, Kawai T, Azuma E, Nakajima T, Shindo M, Kurose K, Sugie A, Yamagishi Y, Fujii-Kuriyama Y and Hashimoto M (2002) Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1,1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice. Carcinogenesis 23: 1199-1207.
95. Whitlock JPJ (1999) Induction of cytochrome P-4501A1. Annu. Rev. Pharmacol. Toxicol. 39: 103-125.
96. Reyes H, Reisz-Porszasz S and Han Mnson O (1992) Identification of the Ah receptor nuclear translocator protein (Amt) as a component of the DNA binding form of the Ah receptor. Science 256: 1193-1195.
97. Nebert DW, Eisen HJ, Negishi M, Lang MA and Hjelmeland LM (1981) Genetic mechanisms controlling the induction of polysubstrate monooxygenase (P-450) activities. Annu. Rev. Pharmacol. Toxicol. 21: 431-462.
98. Nebert DW (1989) The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Crit. Rev. Toxicol. 2: 153-174.
99. Okey AB (1990) Enzyme induction in the cytochrome P450 system. Pharmacol. Ther. 45: 241-298.
100. Nebert DW, Puga A and Vasiliou V (1993) Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann. N.YAcad. Sci. 685: 624-640.
101. Hankinson O (1995) The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35: 307-340.
102. Gu YZ, Hogenesch JB and Bradfield CA (2000) The PAS superfamily: sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 40: 519-561.
103. Hirshfeld FL (1963) The structure of overcrowded aromatic compounds. Part VII. Out-of-plane deformation in benzo[c]phenanthrene and 1,12-di- methylbenzo[c]phenanthrene. J. Chem. Soc. 2126-2135.
104. Rabinowitz JR, Little SB and Lewis-Bevan L (1996) The effect of crowding in the bay/fjord region on the structure and reactivities of polycyclic aromatic hydrocarbons and their metabolites: quantum mechanical studies. Polycycl. Aromat. Compds. 11: 237-244.
105. Katz AK, Carrell HL and Glusker JP (1998) Dibenzo[a,l]pyrene (dibenzo- [def,p]chrysene): fjord-region distortions. Carcinogenesis 19: 1641-1648.
106. Fretland AJ and Omiecinski CJ (2000) Epoxide hydrolases: biochemistry and molecular biology. Chem.-Biol, Interact. 129: 41-59.
107. Oesch F (1973) Mammalian epoxide hydrases: inducible enzymes catalyzing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica 3: 305-340.
108. Bentley P, Schmassmann H, Sims P and Oesch F (1976) Epoxides derived from various polycyclic hydrocarbons as substrates of homogeneous and microsome-bound epoxide hydratase. A general assay and kinetic properties. Eur. J. Biochem. 69: 97-103.
109. Guenther TM and Oesch F (1981) Microsomal epoxide hydrolase and its role in polycyclic aromatic hydrocarbon biotransformation. In: Polycyclic Hydrocarbons and Cancer [Gelboin HV and Ts’o POP (eds.)] Volume III, pp 183-212, Academic Press, New York.
110. Guengerich FP (1982) Epoxide hydrolase: properties and metabolic roles. Rev. Biochem. Toxicol. 4: 5-30.
111. Raphael D, Glatt HR, Protic-Sabljic M and Oesch F (1982) Effects of various enzyme inducers on monooxygenase, glutathione 5-transferase and epoxide hydrolase activities in cultured hepatoma cells. Chem.-Biol. Interact. 42: 27-43.
112. Astrom A, Maner S and DePierre JW (1987) Induction of liver microsomal epoxide hydrolase, UDP-glucuronyl transferase and cytosolic glutathione transferase in different rodent species by 2-acetylaminofluorene or 3-methylcholanthrene. Xenobiotica 17: 155-163.
113. Hassett C, Laurenzana EM, Sidhu JS and Omiecinski CJ (1998) Effects of chemical inducers on human microsomal epoxide hydrolase in primary hepatocyte cultures. Biochem. Pharmacol 55: 1059-1069.
114. Boyland E and Levi AA (1935) Metabolism of polycyclic compounds. I. Production of dihydroxydihydroanthracene from anthracene. Biochem. J. 29: 2679-2683.
115. Armstrong RN (1987) Enzyme-catalyzed detoxication reactions: mechanisms and stereochemistry. Crit. Rev. Biochem. Mol. Biol. 22: 39-88.
116. Shou M, Gonzalez FJ and Gelboin HV (1996) Stereoselective epoxidation and hydration at the K-region of polycyclic aromatic hydrocarbons by cDNA-expressed cytochromes P450 1A1, 1A2, and epoxide hydrolase. Biochemistry 35: 15807-15813.
117. Lacourciere GM and Armstrong RN (1993) The catalytic mechanism of microsomal epoxide hydrolase involves an ester intermediate. J. Am. Chem. Soc. 115: 10466-10467.
118. 404 with Asp leads to a strongly increased turnover rate. Biochem. J. 337: 37-43.
119. Phillips DH and Grover PL (1994) Polycyclic hydrocarbon activation: bay regions and beyond. Drug Metab. Rev. 26: 443-467.
120. Shimada T, Martin MV, Pruess-Schwartz D, Marnett L and Guengerich FP (1989) Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo[a]pyrene, 7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer Res. 49: 6304-6312.
121. Marnett LJ and Bienkowski MJ (1980) Hydroperoxide-dependent oxygenation of trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene by ram seminal vesicle microsomes, source of oxygen. Biochem. Biophys. Res. Commun. 96: 639-647.
122. Sivarajah K, Lasker JM and Eling TA (1981) Prostaglandin synthetase-dependent cooxidation of (±)-benzo[a]pyrene-7,8-dihydrodiol by human lung and other mammalian tissues. Cancer Res. 41: 1834-1839.
123. Guthrie J, Robertson IGC, Zeiger E, Boyd JA and Eling TE (1982) Selective activation of some dihydrodiols of several polycyclic aromatic hydrocarbons to mutagenic products by prostaglandin synthetase. Cancer Res. 42: 1620-1623.
124. Reed GA and Marnett LJ (1982) Metabolism and activation of 7,8-dihydroxy-benzo[a]pyrene during prostaglandin biosynthesis. Intermediacy of a bay-region epoxide. J. Biol. Chem. 257: 11368-11376.
125. Dix TA and Marnett LJ (1983) Metabolism of polycyclic aromatic hydrocarbon derivatives to ultimate carcinogens during lipid peroxidation. Science 221: 77-79.
126. Marnett LJ (1985) Hydroperoxide-dependent oxygenation of polycyclic aromatic hydrocarbons and their metabolites. In: Polycyclic Hydrocarbons and Carcinogenesis [Harvey RG (ed.)] ACS Symposium Series 283, pp 307-326, American Chemical Society, Washington, D.C.
127. Pruess-Schwartz D, Nimesheim A, and Mamett LJ (1989) Peroxyl radical- and cytochrome P450-dependent metabolic activation of (+)-7,8-dihydroxy- 7,8- dihydrobenzo[a]pyrene in mouse skin in vitro and in vivo. Cancer Res. 49: 1732-1737.
128. Mamett LJ (1990) Prostaglandin synthase-mediated metabolism of carcinogens and a potential role for peroxyl radicals as reactive intermediates. Environ. Health Perspect. 88: 5-12.
129. Eling TE, Thompson DC, Foureman GL, Curtis JF and Hughes MF (1990) Prostaglandin H synthase and xenobiotic oxidation. Annu. Rev. Pharmacol. Toxicol. 30: 1-45.
130. O’Brien PJ (2000) Peroxidases. Chem.-Biol. Interact. 129: 113-139.
131. Wiese FW, Thompson PA and Kadlubar FF (2001) Carcinogen substrate specificity of human COX-1 and COX-2. Carcinogenesis 22: 5-10.
132. Mallet WG, Mosebrook DR and Trash MA (1991) Activation of (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to diolepoxides by human polymorphonuclear leukocytes or myeloperoxidase. Carcinogenesis 12: 521-524.
133. Trash A, Esterline RL, Mallet WG, Mosebrook DR and Twerdok LE (1991) Further evidence for the role of myeloperoxidase in the activation of benzo[a]pyrene-7,8-dihydrodiol by polymorphonuclear leukocytes. Adv. Exp. Med. Biol. 283: 399-401.
134. Petruska JM, Mosebrook DR, Jakab GJ and Trash MA (1992) Myeloperoxidase-enhanced formation of (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]-pyrene-DNA adducts in lung tissue in vitro: a role of pulmonary infl ammation in the bioactivation of a procarcinogen. Carcinogenesis 13: 1075-1081.
135. Borm PJA, Knaapen AM, Schins RPF, Godschalk RWL and van Schooten FJ (1997) Neutrophils amplify the formation of DNA adducts by benzo[a]pyrene in lung target cells. Environ. Health Perspect. 105, Suppl 5: 1089-1093.
136. Josephy PD and Coomber BL (1998) Current concepts: neutrophils and the activation of carcinogens in the breast and other organs. Can. J. Physiol. Pharmacol. 76: 693-700.
137. Madhavan ND and Naidu KA (2000) Purification and partial characterization of peroxidase from human term placenta of non-smokers: metabolism of benzo[a]pyrene-7,8-dihydrodiol. Placenta 21: 501-509.
138. Rojas M, Godschalk R, Alexandrov K, Cascorbi I, Kriek E, Ostertag J, van Schooten FJ and Bartsch H (2001) Myeloperoxidase -463A variant reduces benzo[a]pyrene diol epoxide DNA adducts in skin of coal tar treated patients. Carcinogenesis 22: 1015-1018.
139. Kelley DJ, Mestre JR, Subbarmaiah K, Sacks PG, Schantz SP, Tanabe T, Inoue H, Ramonettie JT and Dannenberg AJ (1997) Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells. Carcinogenesis 18: 795-799.
140. Marks F and Fürstenberger G (2000) Cancer chemoprevention through interruption of multistage carcinogenesis: the lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer. Eur. J. Cancer 36: 314-329.
141. Devanesan P, Rogan E and Cavalieri E (1987) The relationship between ionisation potential and prostaglandin H synthase-catalyzed binding of aromatic hydrocarbons to DNA. Chem.-Biol. Interact. 61: 89-95.
142. Cavalieri EL and Rogan EG (1992) The approach to understanding aromatic hydrocarbon carcinogenesis: the central role of radical cations in metabolic activation. Pharmacol. Ther. 55: 183-199.
143. Stansbury KH and Trush MA (1999) Evidence for dialdehyde/imine intermediate formation during the metabolism ofbenzo[a]pyrene-7,8-dihydrodiol by horseradish peroxidase. Polycycl. Aromat. Compds. 16: 225-234.
144. Stansbury KH, Noll DM, Groopman JD and Trush MA (2000) Enzyme-mediated dialdehyde formation: an alternative pathway for benzo[a]pyrene 7,8- dihydrodiol bioactivation. Chem. Res. Toxicol. 13: 1174-1180.
145. Garattini E, Coccia P, Romano M, Jiritano L, Noseda A and Salmona M (1984) Prostaglandin-endoperoxide sythetase and the activation of benzo- [a]pyrene to reactive metabolites in vivo in guinea pigs. Cancer Res. 44: 5150-5155.
146. 32P-postlabelling analysis of DNA adduction in mouse skin following topical administration of (+)-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene. Chem. Res. Toxcicol. 5: 26-33.
147. Melendez-Colon VJ, Luch A, Seidel A and Baird WM (1999) Cancer initiation by polycyclic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sites. Carcinogenesis 20: 1885-1891.
148. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghom AD, Mehta RG, Moon RC and Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220.
149. Müller-Decker K, Kopp-Schneider A, Marks F, Seibert K and Fürstenberger G (1998) Localization of prostaglandin H synthase isoenzymes in murine epidermal tumors: suppression of skin tumor promotion by inhibition of prostaglandin H synthase-2. Mol. Carcinog. 23: 36-44.
150. Abou-Issa HM, Alshafie GA, Seibert K, Koki AT, Masferrer JL and Harris RE (2001) Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis. Anticancer Res. 21: 3425-3432.
151. Müller-Decker K, Neufang G, Berger I, Neumann M, Marks F and Fürstenberger G (2002) Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. Proc. Natl Acad. Sci. USA 99: 12483-12488.
152. Tiano HF, Loftin CD, Akunda J, Lee CA, Spalding J, Sessoms A, Dunson DB, Rogan EG, Morham SG, Smart RC and Langenbach R (2002) Deficiency of either cyclooxygenase (COX)-l or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res. 62: 3395-3401.
153. Adriaenssens PI, Sivarajah K, Boorman GA, Eling TE and Anderson MW (1983) Effect of aspirin and indomethacin on the formation of benzo- [aJpyrene-induced pulmonary adenomas and DNA adducts in A/Hej mice. Cancer Res. 43: 4762-4767.
154. Gupta RA and DuBois RN (2001) Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat. Rev. Cancer 1: 11-21.
155. Williams CS, Mann M and DuBois RN (1999) The role of cyclooxygenase in inflammation, cancer and development. Oncogene 18: 7908-7916.
156. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woemer BM, Edwards DA, Flickinger AG, Moore RJ and Seibert K (2000) Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res. 60: 1306-1311.
157. Leahy KM, Omberg RL, Wang Y, Zweifel BS, Koki AT and Masferrer JL (2002) Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res. 62: 625-631.
158. -463G → A polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev. 9: 181-184.
159. Schabath MB, Spitz MR, Zhang X, Delclos GL and Wu X (2000) Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis 21: 1163-1166.
160. Kiyohara C, Otsu A, Shirakawa T, Fukuda S and Hopkin JM (2002) Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer 37: 241-256.
161. Shimizu Y, Nakatsuru Y, Ichinose M, Takahashi Y, Kume H, Mimura J, Fujii-Kuriyama Y and Ishikawa T (2000) Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. USA 97: 779-782.
162. Robinson JR, Felton JS, Levitt RC, Thorgeirsson SS and Nebert DW (1975) Relationship between “aromatic hydrocarbon responsiveness” and survival times in mice treated with various drugs and environmental compounds. Mol. Pharmacol. 11: 850-865.
163. Uno S, Dalton TP, Shertzer HG, Genter MB, Warshawsky D, Talaska G and Nebert DW (2001) Benzo[a]pyrene-induced toxicity: paradoxical protection in Cyplal(-/-) knockout mice having increased hepatic BaP-DNA adduct levels. Biochem. Biophys. Res. Commun. 289: 1049-1056.
164. Heidel SM, Mac Williams PS, Baird WM, Dashwood WM, Buters JTM, Gonzalez FJ, Larsen MC, Czuprynski CJ and Jefcoate CR (2000) Cytochrome P4501B1 mediates induction of bone marrow cytotoxicity and preleukemia cells in mice treated with 7,12-dimethylbenz[a]anthracene. Cancer Res. 60: 3454-3460.
165. Heidel SM, Holston K, Buters JTM, Gonzalez FJ, Jefcoate CR and Czuprynski CJ (1999) Bone marrow stromal cell cytochrome P4501B1 is required for pre-B cell apoptosis induced by 7,12-dimethylbenz[a]anthracene. Mol. Pharmacol. 56: 1317-1323.
166. Buters JTM, Sakai S, Richter T, Pineau T, Alexander DL, Savas U, Doehmer J, Ward JM, Jefcoate CR and Gonzalez FJ (1999) Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas. Proc. Natl. Acad. Sci. USA 96: 1977-1982.
167. Buters JTM, Mahadevan B, Quintanilla-Martinez L, Gonzalez FJ, Greim H, Baird WM and Luch A (2002) Cytochrome P450 1B1 determines susceptibility to dibenzo[a, l]pyrene-induced tumor formation. Chem. Res. Toxicol. 15: 1127-1135.
168. Buters J, Quintanilla-Martinez L, Schober W, Soballa VJ, Hintermair J, Wolff T, Gonzalez FJ and Greim H (2003) CYP1B1 determines susceptibility to low doses of 7,12-dimethylbenz[a]anthracene-induced ovarian cancers in mice: correlation of CYPlBl-mediated DNA adducts with carcinogenicity. Carcinogenesis 24: 327-334.
169. Miyata M, Kudo G, Lee YH, Yang TJ, Gelboin HV, Femandez-Salguero P, Kimura S and Gonzalez FJ (1999) Targeted disruption of the microsomal epoxide hydrolase gene: microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[w]anthracene. J. Biol. Chem. 274: 23963-23968.
170. 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo. Int. J. Cancer 103: 5-11.
171. Meehan RR, Speed RM, Gosden JR, Rout D, Hutton JJ, Taylor BA, Hilkens J, Kroezen V, Hilgers J, Adesnik M, Friedberg T, Hastie ND and Wolf CR (1988) Chromosomal organization of the cytochrome P450-2C gene family in the mouse: a locus associated with constitutive aryl hydrocarbon hydroxylase. Proc. Natl. Acad. Sci. USA 85: 2662-2666.
172. Yang SK, McCourt DW, Roller PP and Gelboin HV (1976) Enzymatic conversion of benzo[a]pyrene leading predominantly to the diol-epoxide r-7,t-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene through a single enantiomer of r-7,t-8-dihydroxy-7,8-dihydrobenzo[a]pyrene. Proc. Natl. Acad. Sci, USA 73: 2594-2598.
173. Thakker DR, Yagi H, Akagi H, Koreeda M, Lu AYH, Levin W, Wood AW, Conney AH and Jerina DM (1977) Metabolism of benzo[a]pyrene: VI. Stereoselective metabolism of benzo[a]pyrene and benzo[a]pyrene 7,8- dihydrodiol to diol epoxides. Chem.-Biol. Interact. 16: 281-300.
174. Yang SK, McCourt DW, Leutz JC and Gelboin HV (1977) Benzo[a]pyrene diol epoxides: mechanisms of enzymatic formation and optically active intermediates. Science 196: 1199-1201.
175. Wood AW, Chang RL, Levin W, Yagi H, Thakker DR, Jerina DM and Conney AH (1977) Differences in mutagenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides. Biochem. Biophys. Res. Commun. 77: 1389-1396.
176. Buening MK, Wislocki PG, Levin W, Yagi H, Thakker DR, Akagi H, Koreeda M, Jerina DM and Conney AH (1978) Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (+)-7β,8a-dihydroxy-9α,10α- epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene. Proc. Natl. Acad. Sci. USA 75: 5358-5361.
177. Slaga TJ, Bracken WJ, Gleason G, Levin W, Yagi H, Jerina DM and Conney AH (1979) Marked differences in the skin tumor-initiating activities of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol- 9,10- epoxides. Cancer Res. 39: 67-71.
178. Yang SK, Mushtaq M and Chiu PL (1985) Stereoselective metabolism and activation of polycyclic aromatic hydrocarbons. In: Polycyclic Hydrocarbons and Carcinogenesis [Harvey RG (ed.)] ACS Symposium Series 283, pp 19-34, American Chemical Society, Washington, D.C.
179. Yang SK (1988) Stereoselectivity of cytochrome P-450 isozymes and epoxide hydrolase in the metabolism of polycyclic aromatic hydrocarbons. Biochem. Pharmacol. 37: 61-70.
180. Thakker DR, Levin W, Yagi H, Wood AW, Conney AH and Jerina DM (1988) Stereoselective biotransformation of polycyclic aromatic hydrocarbons to ultimate carcinogens. In: Stereochemical Aspects of Pharmacologically Active Compounds [Wainer AW and Dryer D (eds.)] pp 271-296, Marcel Dekker, New York.
181. Ittah Y, Thakker DR, Levin W, Croisy-Delcey M, Ryan DE, Thomas PE, Conney AH and Jerina DM (1983) Metabolism of benzo[c]phenanthrene by rat liver microsomes and by a purified monooxygenase system reconstituted with different isozymes of cytochrome P-450. Chem.-Biol. Interact. 45: 15-28.
182. Thakker DR, Levin W, Yagi H, Yeh HJC, Ryan DE, Thomas PE, Conney AH and Jerina DM (1986) Stereoselective metabolism of the (+)-(S,S)- and (-)-(R,R)-enantiomers of trans-3,4-dihydroxy-3,4-dihydro- benzo[c]phenanthrene by rat and mouse liver microsomes and by a purified and reconstituted P-450 system. J. Biol. Chem. 261: 5404-5413.
183. Koreeda M, Moore PD, Wislocki PG, Levin W, Conney AH, Yagi H and Jerina DM (1978) Binding of benzo[a]pyene 7,8-diol 9,10-epoxides to DNA, RNA, and protein of mouse skin occurs with high stereoselectivity. Science 199: 778-781.
184. Praess-Schwartz D, Sebti SM, Gilham PT and Baird WM (1984) Analysis of benzo[a]pyrene:DNA adducts formed in cells in culture by immobilized boronate chromatography. Cancer Res. 44: 4104-4110.
185. Praess-Schwartz D, Baird WM, Yagi H, Jerina DM, Pigott MA and Dipple A (1987) Stereochemical specificity in the metabolic activation of benzo[c]phenanthrene to metabolites that covalently bind to DNA in rodent embryo cell cultures. Cancer Res. 47: 4032-4037.
186. Einholf HJ, Amin S, Yagi H, Jerina DM and Baird WM (1996) Benzo[c]phenanthrene is activated to DNA-binding diol epoxides in the human mammary carcinoma cell line MCF-7 but only limited activation occurs in mouse skin. Carcinogenesis 17: 2237-2244.
187. Einholf HJ, Story WT, Marcus CB, Larsen MC, Jefcoate CR, Greenlee WF, Yagi H, Jerina DM, Amin S, Park SS, Gelboin HV and Baird WM (1997) Role of cytochrome P450 enzyme induction in the metabolic activation of benzo[c]phenanthrene in human cell lines and mouse epidermis. Chem. Res. Toxicol. 10: 609-617.
188. Melendez-Colon VJ, Luch A, Seidel A and Baird WM (2000) Formation of stable DNA adducts and apurinic sites upon metabolic activation of bay and fjord region polycyclic aromatic hydrocarbons in human cell cultures. Chem. Res. Toxicol. 13: 10-17.
189. Wood AW, Richard LC, Levin W, Thakker DR, Yagi H, Sayer JM, Jerina DM and Conney AH (1984) Mutagenicity of the enantiomers of the diastereomeric bay-region benzo[c]phenanthrene 3,4-diol-l,2-epoxides in bacterial and mammalian cells. Cancer Res. 44: 2320-2324.
190. Jerina DM, Sayer JM, Agarwal SK, Yagi H, Levin W, Wood AW, Conney AH, Preuss-Schwarz D, Baird WM, Pigott MA and Dipple A (1986) Reactivity and tumorigenicity of bay-region diol epoxides derived from polycyclic aromatic hydrocarbons. In: Biological Reactive Intermediates III, Mechanisms of Action in Animal Models and Human Diseases [Kocsis JJ, Jollow DJ, Witmer CM, Nelson JO and Snyder R (eds.)] pp 11-30, Plenum Press, New York.
191. Levin W, Chang RL, Wood AW, Thakker DR, Yagi H, Jerina DM and Conney AH (1986) Tumorigenicity of optical isomers of the diastereomeric bay-region 3,4-diol-1,2-epoxides of benzo[c]phenanthrene in murine tumor models. Cancer Res. 46: 2257-2261.
192. Levin W, Wood AW, Chang RL, Ittah Y, Croisy-Celcay M, Yagi H, Jerina DM and Conney AH (1980) Exceptionally high tumor-initiating activity of benzo[c]phenanthrene bay-region diol-epoxides on mouse skin. Cancer Res. 40: 3910-3914.
193. Hecht SS, Radock R, Amin S, Huie K, Melikian AA, Hoffmann D, Pataki J and Harvey RG (1985) Tumorigenicity of 5-methylchrysene dihydrodiols and dihydrodiol epoxides in newborn mice and on mouse skin. Cancer Res. 45:1449-1452.
194. Hecht SS, Melikian AA and Amin S (1986) Methylchrysenes as probes for the mechanism of metabolic activation of carcinogenic methylated polynuclear aromatic hydrocarbons. Acc. Chem. Res. 19: 174-180.
195. Melikian AA, Amin S, Huie K, Hecht SS and Harvey RG (1988) Reactivity with DNA bases and mutagenicity toward Salmonella typhimurium of methylchrysene diol epoxide enantiomers. Cancer Res. 48: 1781-1787.
196. Moschel RC, Baird WM and Dipple A (1977) Metabolic activation of the carcinogen 7,12-dimethylbenz[a]anthracene for DNA binding. Biochem. Biophys. Res. Commun. 76: 1092-1098.
197. Bigger CA, Sawicki JT, Blake DM, Raymond LG and Dipple A (1983) Products of binding of 7,12-dimethylbenz[a]anthracene to DNA in mouse skin. Cancer Res. 43: 5647-5651.
198. Vericat JA, Cheng SC and Dipple A (1989) Absolute stereochemistry of the major 7,12-dimethylbenz[a]anthracene-DNA adducts formed in mouse cells. Carcinogenesis 10: 567-570.
199. Ralston SL, Lau HHS, Seidel A, Luch A, Platt KL and Baird WM (1994) Identification of dibenzo[a, l]pyrene-DNA adducts formed in cells in culture and in mouse skin. Polycycl. Aromat. Compds. 6: 199-206.
200. Ralston SL, Lau HHS, Seidel A, Luch A, Platt KL and Baird WM (1994) The potent carcinogen dibenzo[a,l]pyrene is metabolically activated to fjord-region 11,12-diol 13,14-epoxides in human mammary carcinoma MCF-7 cell cultures. Cancer Res. 54: 887-890.
201. Ralston SL, Seidel A, Luch A, Platt KL and Baird WM (1995) Stereoselective activation of dibenzo[a,l]pyrene to (-)-anti(11R,12S, 135,14R)- and (+)-syn(11S, 12R, 13.S,14R)-11,12-diol-13,14-epoxides which bind extensively to deoxyadenosine residues of DNA in the human mammary carcinoma cell line MCF-7. Carcinogenesis 16: 2899-2907.
202. Meehan T and Straub K (1979) Double-stranded DNA stereoselectively binds benzo[a]pyrene diol epoxides. Nature 277: 410-412.
203. Reardon DB, Prakash AS, Hilton BD, Roman JM, Pataki J, Harvey RG and Dipple A (1987) Characterization of 5-methylchrysene-l,2-dihydrodiol-3,4- epoxide-DNA adducts. Carcinogenesis 8: 1317-1322.
204. Sawicki JT, Moschel RC and Dipple A (1983) Involvement of both syn- and anti-dihydrodiol epoxides in the binding of 7,12-dimethylbenz[a]anthracene to DNA in mouse embryo cell cultures. Cancer Res. 43: 3212-3218.
205. Cheng SC, Prakash AS, Pigott MA, Hilton BD, Roman JM, Lee H, Harvey RG and Dipple A (1988) Characterization of 7,12-dimethylbenz[a]- anthracene-adenine nucleoside adducts. Chem. Res. Toxicol. 1: 216-221.
206. Cavalieri EL, Rogan EG, Higginbotham S, Cremonesi P and Salmasi S (1989) Tumor initiating activity in mouse skin and carcinogenicity in rat mammary gland of dibenzo[a]pyrenes: the very potent environmental carcinogen dibenzo[a,l]pyrene. J. Cancer Res. Clin. Oncol. 115: 67-72.
207. Cavalieri EL and Rogan EG (1984) Role of radical cations in aromatic hydrocarbon carcinogenesis. Environ. Health Perspect. 64: 69-84.
208. Cavalieri EL and Rogan EG (1985) One-electron oxidation in aromatic hydrocarbon carcinogenesis. In: Polycyclic Hydrocarbons and Carcinogenesis [Harvey RG (ed.)] ACS Symposium Series 283, pp 289-305, American Chemical Society, Washington, D.C.
209. Cavalieri EL and Rogan EG (1995) Central role of radical cations in metabolic activation of aromatic hydrocarbon carcinogenesis. Xenobiotica 25: 677-688.
210. Cremonesi P, Cavalieri EL and Rogan EG (1989) One-electron oxidation of 6-substituted benzo[a]pyrenes by manganic acetate. J. Org. Chem. 54: 3561-3570.
211. Rogan EG, Katomski PA, Roth RW and Cavalieri EL (1979) Horseradish peroxidase/hydrogen peroxide-catalyzed binding of aromatic hydrocarbons to DNA. J. Biol. Chem. 254: 7055-7059.
212. Rogan EG, Hakam A and Cavalieri EL (1983) Structure elucidation of a 6-methylbenzo[a]pyrene-DNA adduct formed by horseradish peroxidase in vitro and mouse skin in vivo. Chem.-Biol. Interact. 47: 111-122.
213. Rogan EG, Cavalieri EL, Tibbels S, Cremonesi P, Warner C, Nagel D, Tomer K, Cemy R and Gross M (1988) Synthesis and identification of benzo[a]pyrene-guanine nucleoside adducts formed by electrochemical oxidation and horseradish peroxidase-catalyzed reaction of benzo[a]pyrene with DNA. J. Am. Chem. Soc. 110: 4023-4029.
214. Cavalieri EL, Rogan EG, Devanesan PD, Cremonesi P, Cemy RL, Gross ML and Bodell WJ (1990) Binding of benzo[a]pyrene to DNA by cytochrome P-450-catalyzed one-electron oxidation in rat liver microsomes and nuclei. Biochemistry 29: 4820-4827.
215. RamaKrishna NV, Devanesan PD, Rogan EG, Cavalieri EL, Jeong H, Jankowiak R and Small GJ (1992) Mechanism of metabolic activation of the potent carcinogen 7,12-dimethylbenz[a]anthracene. Chem. lies. Toxicol. 5: 220-226.
216. Devanesan PD, RamaKrishna NYS, Todorovic R, Rogan EG, Cavalieri EL, Jeong H, Jankowiak R and Small GJ (1992) Identification and quantitation of benzo[a]pyrene-DNA adducts formed by rat liver microsomes in vitro. Chem. Res. Toxicol. 5: 302-309.
217. Rogan EG, Devanesan PD, RamaKrishna NVS, Higginbotham S, Padmavathi NS, Chapman K, Cavalieri EL, Jeong H, Jankowiak R and Small GJ (1993) Identification and quantitation of benzo[a]pyrene-DNA adducts formed in mouse skin. Chem. Res. Toxicol. 6: 356-363.
218. Devanesan PD, RamaKrishna NVS, Padmavathi NS, Higginbotham S, Rogan EG, Cavalieri EL, Marsch GA, Jankowiak R and Small GJ (1993) Identification and quantitation of 7,12-dimethylbenz[a]anthracene-DNA adducts formed in mouse skin. Chem. Res. Toxicol. 6: 364-371.
219. Chen L, Devanesan PD, Higginbotham S, Ariese F, Jankowiak R, Small GJ, Rogan EG and Cavalieri EL (1996) Expanded analysis of benzo[a]pyrene- DNA adducts formed in vitro and in mouse skin: their significance in tumor initiation. Chem. Res. Toxicol. 9: 897-903.
220. Hanson AA, Li KM, Lin CH, Jankowiak R, Small GJ, Rogan EG and Cavalieri EL (2000) Synthesis and structure determination of 6-methyl- benzo[a]pyrene-deoxyribonucleoside adducts and their identification and quantitation in vitro and in mouse skin. Chem.-Biol. Interact. 128: 65-90.
221. Cavalieri EL, Rogan EG, Roth RW, Saugier RK and Hakam A (1983) The relationship between ionization potential and horseradish peroxidase/hydrogen peroxide-catalyzed binding of aromatic hydrocarbons to DNA. Chem.-Biol. Interact. 47: 87-109.
222. Estabrook RW, Werringloer J, Capdevila J and Prough RA (1978) The role of cytochrome P-450 and the microsomal electron transport system: the oxidative metabolism of benzo[a]pyrene. In: Polycyclic Hydrocarbons and Cancer [Gelboin HV and Ts’o POP (eds.)] Volume I: Environment, Chemistry, and Metabolism, pp 285-319, Academic Press, New York.
223. Phillips DH and Sims P (1979) Polycyclic aromatic hydrocarbon metabolites: their reactions with nucleic acids. In: Chemical Carcinogens and DNA [Grover PL (ed.)] pp 29-57, CRC Press, Boca Raton, FL.
224. Grover PL (1986) Pathways involved in the metabolism and activation of polycyclic hydrocarbons. Xenobiotica 16: 915-931.
225. Holder G, Yagi H, Dansette P, Jerina DM, Levin W, Liu AYH and Conney AH (1974) Effects of inducers and epoxide hydrase on the metabolism of benzo[a]pyrene by liver microsomes and a reconstituted system: analysis by high-pressure liquid chromatography. Proc. Natl. Acad. Sci. USA 71: 4356-4360.
226. Yang SK, Roller PP and Gelboin HV (1977) Enzymatic mechanism of benzo[a]pyrene conversion to phenols and diols and an improved high- pressure liquid chromatographic separation of benzo[a]pyrene derivatives. Biochemistry 16: 3680-3687.
227. Gelboin HV (1980) Benzo[a]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol. Rev. 60: 1107-1166.
228. Nagata C, Tagashira Y and Kodama M (1974) Metabolic activation ofbenzo- [a]pyrene: significance of the free radical. In: Chemical Carcinogenesis [Ts’o POP and DiPaolo JA (eds.)] Part A, pp 87-111, Marcel Dekker, New York.
229. Lorentzen RJ, Caspary WJ, Lesko SA and Ts’o POP (1975) The autooxidation of 6-hydroxybenzo[a]pyrene and 6-oxobenzo[a]pyrene radical, reactive metabolites of benzo[a]pyrene. Biochemistry 14: 3970-3977.
230. Lesko SA, Caspary W, Lorentzen RJ and Ts’o POP (1975) Enzymic formation of 6-oxobenzo[a]pyrene radical in rat liver homogenates for carcinogenic benzo[a]pyrene. Biochemistry 14: 3978-3984.
231. Lesko SA, Lorentzen RJ and Ts’o POP (1978) Benzo[a]pyrene metabolism: one-electron pathway and the role of nuclear enzymes. In: Polycyclic Hydrocarbons and Cancer [Gelboin HV and Ts’o POP (eds.)] Volume I: Environment, Chemistry, and Metabolism, pp 261-269, Academic Press, New York.
232. Buhler DR, Unlü F, Thakker DR, Slaga TJ, Conney AH, Wood AW, Chang RL, Lewin W and Jerina DM (1983) Effect of 6-fluoro substituent on the metabolism and biological activity of benzo[a]pyrene. Cancer Res. 43: 1541-1549.
233. Cavalieri EL, Rogan EG, Cremonesi P and Devanesan PD (1988) Radical cations as precursors in the metabolic formation of quinones from benzo[a]pyrene and 6-fluorobenzo[a]pyrene: fluoro substitution as a probe for one-electron oxidation in aromatic substrates. Biochem. Pharmacol. 37: 2173-2182.
234. Cavalieri EL, Devanesan PD and Rogan EG (1988) Radical cations in the horseradish peroxidase- and prostaglandin H synthase-mediated metabolism and binding of benzo[a]pyrene to deoxyribonucleic acid. Biochem. Pharmacol. 37: 2183-2187.
235. Daly JW, Jerina DM and Witkop B (1972) Arene oxides and the NIH shift: the metabolism, toxicity and carcinogenicity of aromatic compounds. Experientia 28: 1129-1164.
236. Yang SK, Roller PP, Fu PP, Harvey RG and Gelboin HV (1977) Evidence for a 2,3-epoxide as an intermediate in the microsomal metabolism of benzo[a]pyrene to 3-hydroxybenzo[a]pyrene. Biochem. Biophys. Res. Commun. 77: 1176-1182.
237. Mulder PPJ, Devanesan P, van Alem K, Lodder G, Rogan EG and Cavalieri EL (2003) Fluorobenzo[a]pyrenes as probes of the mechanism of cytochrome P450-catalyzed oxygen transfer in aromatic oxygenations. Free Radic. Biol. Med. 34: 734-745.
238. Li KM, Todorovic R, Rogan EG, Cavalieri EL, Ariese F, Suh M, Jankowiak R and Small GJ (1995) Identification and quantitation of dibenzo[a, l]pyrene- DNA adducts formed by rat liver microsomes in vitro: preponderance of depurination adducts. Biochemistry 34: 8043-8049.
239. Todorovic R, Ariese F, Devanesan PD, Jankowiak R, Small GJ, Rogan EG and Cavalieri EL (1997) Determination of benzo[a]pyrene- and 7,12-di- methylbenz[a]anthracene-DNA adducts formed in rat mammary glands. Chem. Res. Toxicol. 10: 941-947.
240. Chakravarti D, Mailander P, Franzen J, Higginbotham S, Cavalieri EL and Rogan EG (1998) Detection of dibenzo[a]pyrene-induced H-ras codon 61 mutant gene in preneoplastic SENCAR mouse skin using a new PCR-RFLP method. Oncogene 16: 3203-3210.
241. Chakravarti D, Pelling JC, Cavalieri EL and Rogan EG (1995) Relating aromatic hydrocarbon-induced DNA adducts and c-Ha-ras mutations in mouse skin papillomas: the role of apurinic sites. Proc. Natl. Acad. Sci. USA 92: 10422-10426.
242. Cavalieri EL and Rogan EG (1996) The primary role of apurinic sites in tumor initiation. Polycycl. Aromat. Compds. 10: 251-258.
243. Cavalieri EL and Rogan EG (2002) A unified mechanism in the initiation of cancer. Ann. N.Y. Acad. Sci. 959: 341-354.
244. Chakravarti D, Mailander PC, Cavalieri EL and Rogan EG (2000) Evidence that error-prone DNA repair converts dibenzo[a,l]pyrene-induced depuri- nating lesions into mutations: formation, clonal proliferation and regression of initiated cells carrying H-ras oncogene mutations in early preneoplasia. Mutat. Res. 456: 17-32.
245. Lorentzen RJ and Ts’o POP (1977) Benzo[a]pyrenedione/benzo[a]pyrenediol oxidation-reduction couples and the generation of reactive reduced molecular oxygen. Biochemistry 16: 1467-1473.
246. Cerutti P, Shinohara K, Ide ML and Remsen J (1978) Formation and repair of benzo[a]pyrene-induced DNA damage in mammalian cells. In: Polycyclic Hydrocarbons and Cancer [Gelboin HV and Ts’o POP (eds.)] Volume II: Molecular and Cell Biology, pp 203-212, Academic Press, New York.
247. Chevion M (1988) A site-specific mechanism for free radical induced biological damage: the essential role of redox-active transition metals. Free Radic. Biol. Med. 5: 27-37.
248. Blakely WF, Fuciarelli AF, Wegher BJ and Dizdaroglu M (1990) Hydrogen peroxide-induced base damage in deoxyribonucleic acid. Radiat. Res. 121: 338-343.
249. Leadon SA, Stampfer MR and Bartley J (1988) Production of oxidative DNA damage during the metabolic activation of benzo[a]pyrene in human mammary epithelial cells correlates with cell killing. Proc. Natl. Acad. Sci. USA 85: 4365-4368.
250. Frenkel K, Wei L and Wei H (1995) 7,12-Dimethylbenz[a]anthracene induces oxidative DNA modification in vivo. Free Radio. Biol. Med. 19: 373-380.
251. Mauthe RJ, Cook VM, Coffing SL and Baird WM (1995) Exposure of mammalian cell cultures to benzo[a]pyrene and light results in oxidative DNA damage as measured by 8-hydroxydeoxyguanosine formation. Carcinogenesis 16: 133-137.
252. Kim KB and Lee BM (1997) Oxidative stress to DNA, protein, and antioxidant enzymes (superoxide dismutase and catalase) in rats treated with benzo[a]pyrene. Cancer Lett. 113: 205-212.
253. Joseph P and Jaiswal AK (1994) NAD(P)H:quinone oxidoreductasei (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone- DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc. Natl. Acad. Sci. USA 91: 8413-8417.
254. Joseph P and Jaiswal AK (1998) NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NAD(P)H:P450 reductase-activated metabolites of benzo[a]pyrene quinones. Br. J. Cancer 11: 709-719.
255. Long II DJ, Waikel RL, Wang XJ, Perlaky L, Roop DR and Jaiswal AK (2000) NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo[a]pyrene-induced mouse skin carcinogenesis. Cancer Res. 60: 5913-5915.
256. Long II DJ, Waikel RL, Wang XJ, Roop DR and Jaiswal AK (2001) NAD(P)H: quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[a]anthracene-induced carcinogenesis in mouse skin. J. Natl. Cancer Inst. 93: 1166-1170.
257. Joseph P, Long II DJ, Klein-Szanto AJ and Jaiswal AK (2000) Role of NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity. Biochem. Pharmacol. 60: 207-214.
258. Berenblum I and Schoental R (1943) The metabolism of B[a]P in mice and rats. I. The isolation of a hydroxy and a quinone derivative, and a consideration of their biological significance. Cancer Res. 3: 145-150.
259. Yang Y, Griffiths WJ, Nordling M, Nygren J, Möller L, Bergman J, Liepinsh E, Otting G, Gustafsson JA, Rafter J and Sjövall J (2000) Ring opening of benzo[a]pyrene in the germ-free rat is a novel pathway for formation of potentially genotoxic metabolites. Biochemistry 39: 15585-15591.
260. Nordling MM, Nygren J, Bergman J, Sundberg K and Rafter JJ (2002) Toxicological characterization of a novel in vivo benzo[a]pyrene metabolite, 7-oxo-benz[d]anthracene-3,4-dicarboxylic acid anhydride. Chem. Res. Toxicol. 15: 1274-1280.
261. Smithgall TE, Harvey RG and Penning TM (1986) Regio- and stereospeci- ficity of homogenous 3α-hydroxysteroid-dihydrodiol dehydrogenase for trans-dihydrodiol metabolites of polycyclic aromatic hydrocarbons. J. Biol. Chem. 261: 6184-6191.
262. Smithgall TE, Harvey RG and Penning TM (1988) Spectroscopic identification of ortho-quinones as the products of polycyclic aromatic trans- dihydrodiol oxidation catalyzed by dihydrodiol dehydrogenase. A potential route of proximate carcinogen metabolism. J. Biol. Chem. 263: 1814-1820.
263. Glatt HR, Vogel K, Bentley P and Oesch F (1979) Reduction of benzo[a]- pyrene mutagenicity by dihydrodiol dehydrogenase. Nature 277: 319-320.
264. Vogel K, Bentley P, Platt KL and Oesch F (1980) Rat liver cytoplasmic dihydrodiol dehydrogenase. Purification to apparent homogeneity and properties. J. Biol. Chem. 255: 9621-9625.
265. Penning TM, Mukharji I, Barrows S and Talalay P (1984) Purification and properties of a 3α-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs. Biochem. J. 222: 601-611.
266. Penning TM, Burczynski ME, Hung CF, McCoull K, Palackal NT and Tsuruda LS (1999) Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: generation of reactive and redox active o-quinones. Chem. Res. Toxicol. 12: 1-18.
267. Hyndman D, Bauman DR, Heredia VV and Penning TM (2003) The aldo- keto reductase superfamily homepage (www.med.upenn.edu/akr). Chem.- Biol. Interact. 143-144: 621-631.
268. Burczynski ME, Harvey RG and Penning TM (1998) Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the activated o-quinone metabolite of benzo[a]pyrene-7,8-dione. Biochemistry 37: 6781-6790.
269. Bolton JL, Trash MA, Penning TM, Dryhurst G and Monks TJ (2000) Role of quinones in toxicology. Chem. Res. Toxicol. 13: 135-160.
270. Palackal NT, Lee SH, Harvey RG, Blair IA and Penning TM (2002) Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells. J. Biol. Chem. 277: 24799-24808.
271. Burczynski ME, Lin HK and Penning TM (1999) Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. Cancer Res. 59: 607-614.
272. Palackal NT, Burczynski ME, Harvey RG and Penning TM (2001) The ubiquitous aldehyde reductase (AKR1A1) oxidizes proximate carinogen trans-dihydrodiols to o-quinones: potential role in polycyclic aromatic hydrocarbon activation. Biochemistry 40: 10901-10910.
273. Palackal NT, Burczynski ME, Harvey RG and Penning TM (2001) Metabolic activation of polycyclic aromatic hydrocarbon trans-dihydrodiols by ubiquitously expressed aldehyde reductase (AKR1A1). Chem.-Biol. Interact. 130-132: 815-824.
274. Penning TM, Ohnishi ST, Ohnishi T and Harvey RG (1996) Generation of reactive oxygen species during the enzymatic oxidation of polycyclic aromatic hydrocarbon trans-dihydrodiols catalyzed by dihydrodiol dehydrogenase. Chem. Res. Toxicol. 9: 84-92.
275. Flowers-Geary L, Harvey RG and Penning TM (1992) Examination of polycyclic aromatic hydrocarbon o-quinones produced by dihydrodiol dehydrogenase as substrates for redox-cycling in rat liver. Biochem. (Life Sci. Adv.) 11:49-58.
276. Shibutani S, Takeshita M and Grollman AP (1991) Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 349: 431-434.
277. Cheng KC, Cahill DS, Kasai H, Nishimura S and Loeb LA (1992) 8- Hydroxyguanine, an abundant form of oxidative DNA damage, causes G→T and A→ C substitutions. J. Biol. Chem. 267: 166-172.
278. Breen AP and Murphy JA (1995) Reactions of oxy radicals with DNA. Free Radic. Biol. Med. 18: 1033-1077.
279. Flowers L, Ohnishi ST and Penning TM (1997) DNA strand scission by polycyclic aromatic hydrocarbon o-quinones: role of reactive oxygen species, Cu(II)/Cu(I) redox cycling, and o-semiquinone anion radicals. Biochemistry 36: 8640-8648.
280. Yu D, Berlin JA, Penning TM and Field J (2002) Reactive oxygen species generated by PAH o-quinones cause change-in-function mutations in p53. Chem. Res. Toxicol. 15: 832-842.
281. Yamamoto K and Kawanishi S (1989) Hydroxyl free radical is not the main active species in site-specific DNA damage induced by copper (II) ion and hydrogen peroxide. J. Biol. Chem. 264: 15435-15440.
282. Flowers L, Bleczinski WF, Burczynski ME, Harvey RG and Penning TM (1996) Disposition and biological activity of benzo[a]pyrene-7,8-dione. A genotoxic metabolite generated by dihydrodiol dehydrogenase. Biochemistry 35: 13664-13672.
283. Chaudhary AK, Nokubo M, Reddy GR, Yeola SN, Morrow JD, Blair IA and Mamett LJ (1994) Detection of endogenous malondialdehyde-deoxy- guanosine adducts in human liver. Science 265: 1580-1582.
284. Plastaras JP, Dedon PC and Mamett LJ (2002) Effects of DNA structure on oxopropenylation by the endogenous mutagens malondialdehyde and base propenal. Biochemistry 41: 5033-5042.
285. Mamett LJ (2002) Oxy radicals, lipid peroxidation and DNA damage. Toxicology 181-182: 219-222.
286. Murty VS and Penning TM (1992) Characterization of mercapturic acid and glutathionyl conjugates of benzo[a]pyrene-7,8-dione by two-dimensional NMR. Bioconjug. Chem. 3: 218-224.
287. Shou M, Harvey RG and Penning TM (1993) Reactivity of benzo[a]pyrene- 7,8- dione with DNA. Evidence for the formation of deoxyguanosine adducts. Carcinogenesis 14: 475-482.
288. McCoull KD, Rindgen D, Blair IA and Penning TM (1999) Synthesis and characterization of polycyclic aromatic hydrocarbon o-quinone depurinating N7-guanine adducts. Chem. Res. Toxicol. 12: 237-246.
289. Penning TM, Palackal NT, Blair IA and Harvey RG (2002) The aldo- keto reductases and polycyclic aromatic hydrocarbon activation. Polycycl. Aromat. Compds. 22: 791-800.
290. Flowers-Geary L, Bleczinski W, Harvey RG and Penning TM (1996) Cytotoxicity and mutagenicity of polycyclic aromatic hydrocarbon ortho- quinones produced by dihydrodiol dehydrogenase. Chem.-Biol. Interact. 99: 55-72.
291. Hecht SS, Amin S, Rivenson A and Hoffmann D (1979) Tumor initiating activity of 5,11-dimethylchrysene and the structural requirements favoring carcinogenicity of methylated polynuclear aromatic hydrocarbons. Cancer Lett. 8: 65-70.
292. Amin S, Misra B, Braley J and Hecht SS (1991) Comparative tumorigenicity in newborn mice of chrysene- and 5-alkylchrysene-1,2-diol-3,4-epoxides. Cancer Lett. 58: 115-118.
293. Geacintov NE, Cosman M, Hingerty BE, Amin S, Broyde S and Patel DJ (1997) NMR solution structures of stereoisomeric covalent polycyclic aromatic carcinogen-DNA adducts: principles, patterns, and diversity. Chem. Res. Toxicol. 10: 111-146.
294. Flesher JW and Sydnor KL (1971) Carcinogenicity of derivatives of 7,12- dimethylbenz[a]anthracene. Cancer Res. 31: 1951-1954.
295. Flesher JW and Sydnor KL (1973) Possible role of 6-hydroxymethylbenzo- [a]pyrene as a proximate carcinogen of benzo[a]pyrene and 6-methyl- benzo[a]pyrene. Int. J. Cancer 11: 433-437.
296. Watabe T, Ishizuka T, Isobe M and Ozawa N (1982) A 7-hydroxymethyl sulfate ester as an active metabolite of 7,12-dimethylbenz[a]anthracene. Science 215: 403-405.
297. Miller EC and Miller JA (1986) Electrophilic sulfuric acid ester metabolites as ultimate carcinogens. Adv. Exp. Med. Biol. 197: 583-595.
298. Baird WM, Dipple A, Grover PL, Sims P and Brookes P (1973) Studies on the formation of hydrocarbon-deoxyribonucleoside products by the binding of derivatives of 7-methylbenz[a]anthracene to DNA in aqueous solution and in mouse embryo cells in culture. Cancer Res. 33: 2386-2392.
299. Rayman MP and Dipple A (1973) Structure and activity in chemical carcinogenesis. Comparison of the reactions of 7-bromomethylbenz [a ] anthracene and 7-bromomethyl-12-methylbenz[a]anthracene with deoxyribonucleic acid in vitro. Biochemistry 12: 1202-1207.
300. Wettstein JG, Chien MT and Flesher JW (1979) DNA binding and mutagenicity of 7-substituted derivatives of benz[a]anthracene. Drug Chem. Toxicol. 2: 383-396.
301. Tay LK, Sydnor KL and Flesher JW (1979) Binding of 6-hydroxymethyl- benzo[a]pyrene and 6-acetoxymethylbenzo[a]pyrene to DNA. Chem.-Biol. Interact. 25: 35-44.
302. Dipple A, Moschel RC and Hudgins WR (1982) Selectivity of alkylation and aralkylation of nucleic acid components. Drug Metab. Rev. 13: 249-268.
303. Rogan EG, Roth RW, Katomski-Beck PA, Laubscher JR and Cavalieri EL (1980) Nonenzymatic ATP-mediated binding of hydroxymethyl derivatives of aromatic hydrocarbons to DNA. Chem.-Biol. Interact. 31: 51-63.
304. Dipple A, Tomaszewski JE, Moschel RC, Bigger CA, Nebzydoski JA and Egan M (1979) Comparison of metabolism-mediated binding to DNA of 7-hydroxymethyl-12-methylbenz[a]anthracene and 7,12-dimethyl- benz[a]anthracene. Cancer Res. 39: 1154-1158.
305. Watabe T (1983) Metabolic activation of 7,12-dimethylbenz[a]anthracene (DMBA) and 7 -methy lbenz[a ]anthracene (7-MBA) by rat liver P-450 and sulfotransferase. J. Toxicol. Sci. 8: 119-131.
306. Watabe T, Fujieda T, Hiratsuka A, Ishizuka T, Hakamata Y and Ogura K (1985) The carcinogen, 7-hydroxymethyl-12-methylbenz[a]anthracene, is activated and covalently binds to DNA via a sulphate ester. Biochem. Pharmacol. 34: 3002-3005.
307. Watabe T, Hakamata Y, Hiratsuka A and Ogura K (1986) A 7-hydroxymethyl sulphate ester as an active metabolite of the carcinogen, 7-hydroxy- methylbenz[a]anthracene. Carcinogenesis 7: 207-214.
308. Okuda H, Hiratsuka A, Nojima H and Watabe T (1986) A hydroxy- methylsulfate ester as an active metabolite of the carcinogen, 5-hydroxy- methylchrysene. Biochem. Pharmacol. 35: 535-538.
309. Watabe T, Ogura K, Okuda H and Hiratsuka A (1989) Hydroxymethyl- sulfate esters as reactive metabolites of the carcinogen, 7-methyl- and 7,12- dimethylbenz[a]anthracenes and 5-methylchrysene. In: Xenobiotic Metabolism and Disposition [Kato R, Estabrook RW and Cayen MN (eds.)] pp 393-400, Taylor and Francis, London.
310. Surh YJ, Liem A, Miller EC and Miller JA (1989) Metabolic activation of the carcinogen 6-hydroxymethylbenzo[a]pyrene: formation of an electrophilic sulfuric acid ester and benzylic DNA adducts in rat liver in vivo and reactions in vitro. Carcinogenesis 10: 1519-1528.
311. Surh YJ, Liem A, Miller EC and Miller JA (1990) The strong hepato- carcinogenicity of the electrophilic and mutagenic metabolite 6-sulfooxy- methylbenzo [a]pyrene and its formation of benzylic DNA adducts in the livers of infant male B6C3F1 mice. Biochem. Biophys. Res. Commun. 172: 85-91.
312. Surh YJ, Liem A, Miller EC and Miller JA (1991) 7-Sulfooxymethyl-12- methylbenz[a]anthracene is an electrophilic mutagen, but does not appear to play a role in carcinogenesis by 7,12-dimethylbenz[a]anthracene or 7-hydroxymethylbenz[a]anthracene. Carcinogenesis 12: 339-347.
313. Flesher JW, Horn J and Lehner AF (1997) 6-Sulfooxymethylbenzo[a]pyrene is an ultimate electrophilic and carcinogenic form of the intermediary metabolite 6-hydroxymethylbenzo[a]pyrene. Biochem. Biophys. Res. Commun. 234: 554-558.
314. Dewhurst F, Kitchen DA and Calcutt G (1972) The carcinogenicity of some 6- substituted benzo[a]pyrene derivatives in mice. Br. J. Cancer 26:506-508.
315. Cavalieri E, Roth R, Grandjean C, Althoff J, Patil K, Liakus S and Marsh S (1978) Carcinogenicity and metabolic profiles of 6-substituted benzo- [a]pyrene derivatives on mouse skin. Chem.-Biol. Interact. 22: 53-67.
316. Sydnor KL, Bergo CH and Flesher JW (1980) Effect of various substituents in the 6-position on the relative carcinogenic activity of a series of benzo[a]pyrene derivatives. Chem.-Biol. Interact. 29: 159-167.
317. Flesher JW, Myers SR and Blake JW (1986) Bioalkylation of polynuclear aromatic hydrocarbons: a predictor of carcinogenic activity. In: Polynuclear Aromatic Hydrocarbons: Chemistry, Characterization and Carcinogenesis [Cooke M and Dennis AJ (eds.)] pp 271-284, Battelle Press, Columbus, OH.
318. Flesher JW, Stansbury KH and Sydnor KL (1982) S-adenosyl-L-methio- nine is a carbon donor in the conversion of benzo[a]pyrene to 6-hydroxy- methylbenzo[a]pyrene by rat liver S-9. Cancer Lett. 16: 91-94.
319. Flesher JW, Myers SR and Stansbury KH (1990) The site of substitution of the methyl group in the bioalkylation of benzo[a]pyrene. Carcinogenesis 11: 493-496.
320. Flesher JW, Myers SR and Blake JW (1984) Biosynthesis of the potent carcinogen 7,12-dimethylbenz[a]anthracene. Cancer Lett. 24: 335-343.
321. Myers SR, Blake JW and Flesher JW (1988) Bioalkylation and biooxidation of anthracene, in vitro and in vivo. Biochem. Biophys. Res. Commun. 151: 1441-1445.
322. Flesher JW and Myers SR (1990) Bioalkylation of benz[a]anthracene as a biochemical probe for carcinogenic activity. Lack of bioalkylation in a series of six noncarcinogenic polynuclear aromatic hydrocarbons. Drug Metab. Disp. 18: 163-167.
323. Myers SR and Flesher JW (1991) Metabolism of chrysene, 5-methyl- chrysene, 6-methylchrysene and 5,6-dimethylchrysene in rat liver cytosol, in vitro, and in rat subcutaneous tissue, in vivo. Chem-Biol. Interact. 77: 203-221.
324. Myers SR and Flesher JW (1991) Bioalkylation of benz[a]anthracene, 7-methylbenz[a]anthracene, and 12-methylbenz[a]anthracene in rat lung cytosol preparations. Biochem. Pharmacol. 41: 1683-1689.
325. Stansbury KH, Flesher JW and Gupta RC (1994) Mechanism of aralkyl- DNA adduct formation from benzo[a]pyrene in vivo. Chem. Res. Toxicol. 7: 254-259.
326. Rice JE, Rivenson A, Braley J and LaVoie EJ (1987) Methylated derivatives of pyrene and fluorene: evaluation of genotoxicity in the hepatocyte/DNA repair test and tumorigenic activity in newborn mice. J. Toxicol. Environ. Health 21: 525-532.
327. Glatt HR, Werle-Schneider G, Enders N, Monnerjahn S, Pudil J, Czich A, Seidel A and Schwarz M (1994) 1-Hydroxymethylpyrene and its sulfuric acid ester: toxicological effects in vitro and in vivo and metabolic aspects. Chem.-Biol. Interact. 92: 305-319.
328. Engst W, Landsiedel R, Hermersdörfer H, Doehmer J and Glatt HR (1999) Benzylic hydroxylation of 1-methylpyrene and 1-ethylpyrene by human and rat cytochromes P450 individually expressed in V79 Chinese hamster cells. Carcinogenesis 20: 1777-1785.
329. Glatt HR (2000) Sulfotransferases in the bioactivation of xenobiotics. Chem.-Biol. Interact. 129: 141-170.
330. Glatt HR, Boeing H, Engelke CEH, Ma L, Kuhlow A, Pabel U, Pomplun D, Teubner W and Meinl W (2001) Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. Mutat. Res. 482: 27-40.
331. Surh YJ, Blomquist JC, Liem A and Miller JA (1990) Metabolic activation of 9-hy droxymethyl-10-methylanthracene and 1 -hydroxy methylpyrene to electrophilic, mutagenic and tumorigenic sulfuric acid esters by rat hepatic sulfotransferase activity. Carcinogenesis 11: 1451-1460.
332. Glatt HR, Henschler R, Phillips DH, Blake JW, Steinberg P, Seidel A and Oesch F (1990) Sulfotransferase-mediated chlorination of 1-hydroxymethylpyrene to a mutagen capable of penetrating indicator cells. Environ. Health Perspect. 88: 43-48.
333. Surh YJ, Blomquist JC and Miller JA (1991) Activation of 1-hy droxymethylpyrene to an electrophilic and mutagenic metabolite by rat hepatic sulfotransferase activity. Adv. Exp. Med. Biol. 283: 383-391.
334. Glatt HR, Bartsch I, Christoph S, Coughtrie MW, Falany CN, Hagen M, Landsiedel R, Pabel U, Phillips DH, Seidel A and Yamazoe Y (1998) Sulfotransferase-mediated activation of mutagens studied using heterologous expression systems. Chem.-Biol. Interact. 109: 195-219.
335. Ma L, Kuhlow A and Glatt HR (2002) Ethanol enhances the activation of 1 -hydroxymethylpyrene to DNA adduct-forming species in the rat. Polycycl. Aromat. Compds. 22: 933-946.
336. Horn J, Flesher JW and Lehner AF (1996) 1-Sulfooxymethylpyrene is an electrophilic mutagen and ultimate carcinogen of 1-methyl- and 1 -hydroxymethylpyrene. Biochem. Biophys. Res. Commun. 228: 105-109.
337. Nemoto N (1981) Glutathione, glucuronide, and sulfate transferase in polycyclic aromatic hydrocarbon metabolism. In: Polycyclic Hydrocarbons and Cancer [Gelboin HV and Ts’o POP (eds.)] Volume III, pp 213-258, Academic Press, New York.
338. Mulder GJ and Jakoby WB (1990) Sulfation. In: Conjugation Reactions in Drug Metabolism: An Integrated Approach [Mulder GJ (ed.)] pp 107-162, Taylor & Francis, London.
339. Mulder GJ, Coughtrie MWH and Burchell B (1990) Glucuronidation. In: Conjugation Reactions in Drug Metabolism: An Integrated Approach [Mulder GJ (ed.)] pp 51-106, Taylor & Francis, London.
340. Tephly TR and Burchell B (1990) UDP-glucuronosyltransferases: a family of detoxifying enzymes. Trends Pharmacol. Sci. 11: 276-279.
341. Bock KW (1991) Roles of UDP-glucuronosyltransferases in chemical carcinogenesis. Crit. Rev. Biochem. Mol. Biol. 26: 129-150.
342. Ritter JK (2000) Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. Chem.-Biol. Interact. 129:171-193.
343. Nemoto N, Takyama S, Nagao M and Umezawa K (1978) Modification of the mutagenicity of benzo[a]pyrene on bacteria by substrates of enzymes producing water soluble conjugates. Toxicol. Lett. 2: 205-211.
344. Owens IS, Koteen GM and Legraverend C (1979) Mutagenesis of certain benzo[a]pyrene phenols in vitro following further metabolism by mouse liver. Biochem. Pharmacol. 28: 1615-1622.
345. Hu Z and Wells PG (1992) In vitro and in vivo biotransformation and covalent binding of benzo[a]pyrene in Gunn and RHA rats with a genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase. J. Pharmacol. Exp. Ther. 263: 334-342.
346. Hu Z and Wells PG (1994) Modulation of benzo[a]pyrene bioactivation by glucuronidation in lymphocytes and hepatic microsomes from rats with a hereditary deficiency in bilirubin UDP-glucuronosyltransferase. Toxicol. Appl. Pharmacol. 127: 306-313.
347. Vienneau DS, DeBoni U and Wells PG (1995) Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo[a]pyrene and benzo[e]pyrene in UDP-glucuronosyl- transferase-deficient cultured rat skin fibroblasts. Cancer Res. 55: 1045-1051.
348. Bock KW, von Clausbruch UC, Kaufmann R, Lilienblum W, Oesch F, Pfeil H and Platt KL (1980) Functional heterogeneity of UDP-glucuronosyltransferase in rat tissues. Biochem. Pharmacol. 29: 495-500.
349. Bock KW, Lipp HP and Bock-Hennig BS (1990) Induction of drug- metabolizing enzymes by xenobiotics. Xenobiotica 20: 1101-1111.
350. Bock KW, Gschaidmeier H, Seidel A, Baird S and Burchell B (1992) Mono- and diglucuronide formation from chrysene and benzo[a]pyrene phenols by 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase (UGT1A1). Mol. Pharmacol. 42: 613-618.
351. Lilienblum W, Bock-Henning BS and Bock KW (1985) Protection against toxic redox cycles between benzo[a]pyrene-3,6-quinone and its quinol by 3- methylcholanthrene-inducible formation of the quinol mono- and diglucuronide. Mol. Pharmacol. 27: 451-458.
352. Gschaidmeier H, Seidel A, Burchell B and Bock KW (1995) Formation of mono- and diglucuronides and other glycosides of benzo[a]pyrene-3,6- quinol by V79 cell-expressed human phenol UDP-glucuronosyltransferases of the UGT1 gene complex. Biochem. Pharmacol. 49: 1601-1606.
353. Jin CJ, Miners JO, Burchell B and Mackenzie PI (1993) The glucuronidation of hydroxylated metabolites of benzo[a]pyrene and 2-acetylaminofluorene by cDNA-expressed human UDP-glucuronosyltransferases. Carcinogenesis 14: 2637-2639.
354. Nemoto N and Gelboin HV (1976) Enzymatic conjugation of benzo[a]pyrene oxides, phenols and dihydrodiols with UDP-glucuronic acid. Biochem. Pharmacol. 25: 1221-1226.
355. Grove AD, Kessler FK, Metz RP and Ritter JK (1997) Identification of a rat oltripaz-inducible UDP-glucuronosyltransferase (UGT1A7) with activity towards benzo[a]pyrene-7,8-dihydrodiol. J. Biol. Chem. 272: 1621-1627.
356. Fang JL, Beland FA, Doerge DR, Wiener D, Guillemette C, Marques MM and Lazarus P (2002) Characterization of benzo[a]pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP- glucuronosyltransferase enzymes. Cancer Res. 62: 1978-1986.
357. Boyland E and Sims P (1957) Metabolism of polycyclic compounds. 11. The conversion of naphthalene into 2-hydroxy-1 -naphthyl sulphate in the rabbit. Biochem. J. 66: 38-40.
358. Sims P (1962) Metabolism of polycyclic compounds. 19. The metabolism of phenanthrene in rabbits and rats: phenols and sulphuric esters. Biochem. J. 84: 558-563.
359. Richter P, Kauffman FC and Zaleski J (1994) Predominance of glucuronidation over sulfation in metabolism of l-hydroxybenzo[a]pyrene by isolated rat hepatocytes. Toxicol. Lett. 74: 79-90.
360. Surh YJ, Kwon H and Tannenbaum SR (1993) Sulfotransferase-mediated activation of 4-hydroxy- and 3,4-dihydroxy-3,4-dihydrocyclopenta[c,d]- pyrene, major metabolites of cyclopenta[c,d]pyrene. Cancer Res. 53: 1017-1022.
361. Surh YJ and Tannenbaum SR (1995) Sulfotransferase-mediated activation of 7,8,9,10- tetrahydro-7-ol, 7,8-dihydrodiol, and 7,8,9,10-tetraol derivatives of benzo[a]pyrene. Chem. Res. Toxicol. 8: 693-698.
362. Glatt HR, Pauly K, Frank H, Seidel A, Oesch F, Harvey RG and Werle- Schneider G (1994) Substrate-dependent sex differences in the activation of benzylic alcohols to mutagens by hepatic sulfotransferases of the rat. Carcinogenesis 15: 2605-2611.
363. Nemoto N, Takayma S and Gelboin HV (1977) Enzymatic conversion of benzo[a]pyrene phenols, dihydrodiols and quinones to sulfate conjugates. Biochem. Pharmacol. 26: 1825-1829.
364. Nemoto N, Takayama S and Gelboin HV (1978) Sulfate conjugation of benzo[a]pyrene metabolites and derivatives. Chem.-Biol. Interact. 23:19-30.
365. Autrup H (1979) Separation of water-soluble metabolites of benzo[a]pyrene formed by cultured human colon. Biochem. Pharmacol. 28: 1727-1730.
366. Boyland E (1986) The metabolism of foreign compounds and the induction of cancer. Xenobiotica 16: 899-913.
367. Ramesh A, Inyang F, Hood DB, Archibong AE, Knuckles ME and Nyanda AM (2001) Metabolism, bioavailability, and toxicokinetics of benzo[a]pyrene in F-344 rats following oral administration. Exp. Toxicol. Pathol. 53: 275-290.
368. Coles B and Ketterer B (1990) The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit. Rev. Biochem. Mol. Biol. 25:47-70.
369. Armstrong RN (1991) Glutathione 5-transferases: reaction mechanism, structure, and function. Chem. Res. Toxicol. 4: 131-140.
370. Bourne MC and Young L (1934) The metabolism of naphthalene in rabbits. Biochem. J. 28: 803-808.
371. Boyland E and Levi AA (1936) Metabolism of polycyclic compounds. III. Anthrylmercapturic acid. Biochem. J. 30: 1225-1227.
372. Booth J, Boyland E and Sims P (1961) An enzyme from rat liver catalysing conjugations with glutathione. Biochem. J. 79: 516-524.
373. Hayes ID and Strange RC (2000) Glutathione 5-transferase polymorphisms and their biological consequences. Pharmacology 61: 154-166.
374. Grover PL (1974) K-region epoxides of polycyclic hydrocarbons: formation and further metabolism by rat-lung preparations. Biochem. Pharmacol. 23: 333-343.
375. Keysell GR, Booth J and Sims P (1975) Glutathione conjugates as metabolites of benz[a]anthracene. Xenobiotica 5: 439-448.
376. Nemoto N, Gelboin HV, Habig WH, Ketley JN and Jakoby WB (1975) K-region benzo[a]pyrene-4,5-oxide is conjugated by homogeneous glutathione 5-transferases. Nature 255: 512.
377. Glatt HR, Friedberg T, Grover PL, Sims P and Oesch F (1983) Inactivation of a diol-epoxide and a K-region epoxide with high efficiency by glutathione transferase X. Cancer Res. 43: 5713-5717.
378. Jemström B, Martinez M, Meyer DJ and Ketterer B (1985) Glutathione conjugation of the carcinogenic and mutagenic electrophile (±)-7β-8α-dihydroxy- 9α,10β-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene catalyzed by purified rat liver glutathione transferases. Carcinogenesis 6: 85-89.
379. Robertson IGC and Jemström B (1986) The enzymatic conjugation of glutathione with bay-region diolepoxides of benzo[a]pyrene, benz[a]anthracene and chrysene. Carcinogenesis 7: 1633-1636.
380. Hu X, Xia H, Srivastava SK, Herzog C, Awasthi YC, Ji X, Zimniak P and Singh SV (1997) Activity of four allelic forms of glutathione 5-transferase hGSTPl-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem. Biophys. Res. Commun. 238: 397-402.
381. Hayakawa T, Udenfriend S, Yagi H and Jerina DM (1975) Substrate and inhibitors of hepatic glutathione 5-epoxide transferase. Arch. Biochem. Biophys. 170: 438-451.
382. Nemoto N and Gelboin HV (1975) Assay and properties of glutathione- 5-benzo[a]pyrene-4,5-oxide transferase. Arch. Biochem. Biophys. 170:739-742.
383. Waterfall JF and Sims P (1972) Epoxy derivatives of aromatic polycyclic hydrocarbons. Biochem. J. 128: 265-277.
384. Jemström B, Funk M, Frank H, MannervikB and SeidelA (1996) Glutathione 5-transferase Al-l-catalysed conjugation of bay and fjord region diol epoxides of polycyclic aromatic hydrocarbons with glutathione. Carcinogenesis 17: 1491-1498.
385. Sundberg K, Widersten M, Seidel A, Mannervik B and Jemström B (2002) Glutathione conjugation of bay- and fjord-region diol epoxides of polycyclic aromatic hydrocarbons by glutathione transferases Ml-1 and Pl-1. Chem. Res. Toxicol. 10: 1221-1227.
386. Fields WR, Morrow CS, Doss AJ, Sundberg K, JemströmB and Townsend AJ (1998) Overexpression of stably transfected human glutathione 5-transferase Pl-1 protects against DNA damage by benzo[a]pyrene diol-epoxide in human T47D cells. Mol. Pharmacol. 54: 298-304.
387. Hu X, Herzog C, Zimniak P and Singh SV (1999) Differential protection against benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide-induced DNA damage in HepG2 cells stably transfected with allelic variants of pi class human glutathione 5-transferase. Cancer Res. 59: 2358-2362.
388. Sundberg K, Dreij K, Seidel A and Jemström B (2002) Glutathione conjugation and DNA adduct formation of dibenzo[a,l]pyrene and benzo[a]pyrene diol epoxides in V79 cells stably expressing different human glutathione transferases. Chem. Res. Toxicol. 15: 170-179.
389. Henderson CJ, Smith AG, Ure J, Brown K, Bacon EJ and Wolf CR (1998) Increased skin tumorigenesis in mice lacking pi class glutathione 5-transferases. Proc. Natl. Acad. Sci. USA 95: 5275-5280.
390. Nesnow S, Ross JA, Mass MJ and Stoner GD (1998) Mechanistic relationship between DNA adducts, oncogene mutations, and lung tumorigenesis in strain A mice. Exp. Lung Res. 24: 395-305.
391. Ross JA and Nesnow S (1999) Polycyclic aromatic hydrocarbons: correlations between DNA adducts and ras oncogene mutations. Mutat. Res. 424: 155-166.
392. Denissenko MF, Pao A, Tang MS and Pfeifer GP (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 21 A: 430-432.
393. Pfeifer GP and Denissenko MF (1998) Formation and repair of DNA lesions in the p53 gene: relation to cancer mutations. Environ. Mol. Mutagen. 31: 197-205.
394. Colapietro AM, Goodell AL and Smart RC (1993) Characterization of benzo[a]pyrene-initiated mouse skin papillomas for Ha -ras mutations and protein kinase C levels. Carcinogenesis 14: 2289-2295.
395. Quintanilla M, Brown K, Ramsden M and Balmain A (1986) Carcinogen- specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322: 78-80.
396. Strauss BS (1991) The ‘A rule’ of mutagen specificity: a consequence of DNA polymerase bypass of non-instructional lesions? Bioessays 13: 79-84.
397. Autrup H and Seremet T (1986) Excretion of benzo[a]pyrene-Gua adduct in the urine of benzo[a]pyrene-treated rats. Chem.-Biol Interact. 60: 217-226.
398. Rogan EG, RamaKrishna NV, Higginbotham S, Cavalieri EL, Jeong H, Jankowiak R and Small GJ (1990) Identification and quantitation of 7- (benzo[a]pyren-6-yl)guanine in the urine and feces of rats treated with benzo[a]pyrene. Chem. Res. Toxicol. 3: 441-444.
399. Roberts KP, Lin CH, Singhal M, Casale GP, Small GJ and Jankowiak R (2000) On-line identification of depurinating DNA adducts in human urine by capillary electrophoresis-fluorescence line narrowing spectroscopy. Electrophoresis 21: 799-806.
400. Casale GP, Singhal M, Bhattacharya S, RamaNathan R, Roberts KP, Barbacci DC, Zhao J, Jankowiak R, Gross ML, Cavalieri EL, Small GJ, Rennard SI, Mumford JL and Shen M (2001) Detection and quantification of depurinated benzo[a]pyrene-adducted DNA bases in the urine of cigarette smokers and women exposed to household coal smoke. Chem. Res. Toxicol. 14: 192-201.
401. Nakamura J and Swenberg JA (1999) Endogenous apurinic/apyrimidinic sites in genomic DNA of mammalian tissues. Cancer Res. 59: 2522-2526.
402. Atamna H, Cheung I and Ames BN (2000) A method for detecting abasic sites in living cells: age-dependent changes in base excision repair. Proc. Natl. Acad. Sci. USA 97: 686-691.
403. Braithwaite E, Wu X and Wang Z (1999) Repair of DNA lesions: mechanisms and relative repair efficiencies. Mutat. Res. 424: 207-219.
404. Lindahl T (2000) Suppression of spontaneous mutagenesis in human cells by DNA base excision-repair. Mutat. Res. 462: 129-135.
405. Braithwaite E, Wu X and Wang Z (1998) Repair of DNA lesions induced by polycyclic aromatic hydrocarbons in human cell-free extracts: involvement of two excision repair mechanisms in vitro. Carcinogenesis 19: 1239-1246.